rs76583617
Positions:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2
The NM_001199267.2(DGKZ):āc.2660C>Gā(p.Thr887Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00585 in 1,609,084 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.0043 ( 3 hom., cov: 33)
Exomes š: 0.0060 ( 39 hom. )
Consequence
DGKZ
NM_001199267.2 missense
NM_001199267.2 missense
Scores
2
8
9
Clinical Significance
Conservation
PhyloP100: 4.07
Genes affected
DGKZ (HGNC:2857): (diacylglycerol kinase zeta) The protein encoded by this gene belongs to the eukaryotic diacylglycerol kinase family. It may attenuate protein kinase C activity by regulating diacylglycerol levels in intracellular signaling cascade and signal transduction. Alternative splicing occurs at this locus and multiple transcript variants encoding distinct isoforms have been identified. [provided by RefSeq, Nov 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.0153025985).
BP6
Variant 11-46379558-C-G is Benign according to our data. Variant chr11-46379558-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 431729.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1, Benign=1}.
BS2
High AC in GnomAd4 at 652 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DGKZ | NM_001199267.2 | c.2660C>G | p.Thr887Arg | missense_variant | 30/31 | ENST00000456247.7 | NP_001186196.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DGKZ | ENST00000456247.7 | c.2660C>G | p.Thr887Arg | missense_variant | 30/31 | 1 | NM_001199267.2 | ENSP00000395684.2 |
Frequencies
GnomAD3 genomes AF: 0.00429 AC: 653AN: 152250Hom.: 3 Cov.: 33
GnomAD3 genomes
AF:
AC:
653
AN:
152250
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00360 AC: 856AN: 237920Hom.: 5 AF XY: 0.00368 AC XY: 478AN XY: 129872
GnomAD3 exomes
AF:
AC:
856
AN:
237920
Hom.:
AF XY:
AC XY:
478
AN XY:
129872
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00601 AC: 8755AN: 1456716Hom.: 39 Cov.: 31 AF XY: 0.00584 AC XY: 4233AN XY: 724452
GnomAD4 exome
AF:
AC:
8755
AN:
1456716
Hom.:
Cov.:
31
AF XY:
AC XY:
4233
AN XY:
724452
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00428 AC: 652AN: 152368Hom.: 3 Cov.: 33 AF XY: 0.00388 AC XY: 289AN XY: 74514
GnomAD4 genome
AF:
AC:
652
AN:
152368
Hom.:
Cov.:
33
AF XY:
AC XY:
289
AN XY:
74514
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
18
ALSPAC
AF:
AC:
21
ESP6500AA
AF:
AC:
6
ESP6500EA
AF:
AC:
47
ExAC
AF:
AC:
405
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2023 | DGKZ: BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | - - |
atypical cerebral palsy Uncertain:1
Uncertain significance, criteria provided, single submitter | research | TIDEX, University of British Columbia | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
.;.;.;.;.;.;.;T
Eigen
Benign
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Pathogenic
D;D;D;D;D;D;D;D
M_CAP
Benign
D
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Uncertain
T
MutationAssessor
Benign
.;.;.;.;.;.;.;N
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D;D;D;D;D;D;D
REVEL
Uncertain
Sift
Benign
T;D;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
0.20, 0.24
.;.;.;.;B;.;.;B
Vest4
MVP
MPC
1.2
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at